Both in Pharmaceuticals
AbCellera Biologics vs Edgewise Therapeutics
Over the past year ABCL returned +128.5% and EWTX returned +116.5%; their daily moves had a correlation of 0.23.
ABCL +128.5% EWTX +116.5%Growth of $1, one year, split-adjusted
| Metric | ABCL | EWTX |
|---|---|---|
| Price | $12.27 | $38.90 |
| Market cap | $3.98B | $4.22B |
| Today | −6.19% | −0.03% |
| 1 month | −11.8% | −3.9% |
| 6 months | +177.0% | +27.1% |
| Year to date | +258.8% | +56.8% |
| 1 year | +118.3% | +138.2% |
| Revenue growth (YoY) | −76.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −1368.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 60.1× | — |
| Net cash | $540.1M | $460.7M |
| Dividend yield | — | — |
| Volatility (60d) | 94.9% | 41.8% |
| Short % of float | 14.5% | 16.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).